Gene · 1666
Papers3,981
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,981
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| POMC-specific modulation of metabolic and immune pathways via melanocortin-3 receptor signaling. | Mol Omics | 2025 | 40549863 | PubTator, text mining | PubMed |
Response by Duan and Lin to Letter Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics". | Circulation | 2025 | 40549847 | PubTator, text mining | PubMed |
Letter by Wang et al Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics". | Circulation | 2025 | 40549843 | PubTator, text mining | PubMed |
| Erigoster B targeting DECR1 induces ferroptosis of breast cancer cells via promoting phosphatidylcholine/arachidonic acid metabolism. | NPJ Precis Oncol | 2025 | 40467779 | PubTator, text mining | PubMed |
| The role of quercetin in modulating lipid metabolism and enhancing chemotherapy via the STAT3-CPT1B pathway in pancreatic cancer. | Biochem Biophys Res Commun | 2025 | 40412371 | PubTator, text mining | PubMed |
| The induction of quinone oxidoreductases NQO1 and NQO2 by clozapine: Potential implications for clozapine-induced agranulocytosis. | Toxicol Lett | 2025 | 40311769 | PubTator, text mining | PubMed |
| Fluorescence Lifetime Imaging Techniques-A Review on Principles, Applications and Clinical Relevance. | J Biophotonics | 2025 | 39973086 | PubTator, text mining | PubMed |
| Targeting human prostaglandin reductase 1 with Licochalcone A: Insights from molecular dynamics and covalent docking studies. | Biophys Chem | 2025 | 39965292 | PubTator, text mining | PubMed |
| Oxidative Stress Biomarkers in Hypertension. | Curr Med Chem | 2025 | 39757687 | PubTator, text mining | PubMed |
| Ferroptosis: when metabolism meets cell death. | Physiol Rev | 2025 | 39661331 | PubTator, text mining | PubMed |
| From discovery to application: Enabling technology-based optimizing carbonyl reductases biocatalysis for active pharmaceutical ingredient synthesis. | Biotechnol Adv | 2025 | 39647674 | PubTator, text mining | PubMed |
| Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review. | Curr Vasc Pharmacol | 2025 | 39313896 | PubTator, text mining | PubMed |
| Integrative Proteomics-Metabolomics of In Vitro Degeneration of Cardiovascular Cell Lines. | Appl Biochem Biotechnol | 2025 | 39110328 | PubTator, text mining | PubMed |
| Metabolism and HSC fate: what NADPH is made for. | Trends Cell Biol | 2025 | 39054107 | PubTator, text mining | PubMed |
In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent. | J Biomol Struct Dyn | 2025 | 38197406 | PubTator, text mining | PubMed |
| Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism. | Theranostics | 2024 | 39629121 | PubTator, text mining | PubMed |
| Bufalin induces ferroptosis by modulating the 2,4-dienoyl-CoA reductase (DECR1)-SLC7A11 axis in breast cancer. | Phytomedicine | 2024 | 39427521 | PubTator, text mining | PubMed |
| High-throughput identification of calcium-regulated proteins across diverse proteomes. | Cell Rep | 2024 | 39425928 | PubTator, text mining | PubMed |
| Cofactor-dependence alteration of 7β-hydroxysteroid dehydrogenase: Enhancing one-pot synthesis efficiency of chenodeoxycholic acid to ursodeoxycholic acid through cofactor self-recycling. | Int J Biol Macromol | 2024 | 39378924 | PubTator, text mining | PubMed |
| NoxO1 Determines the Level of ROS Formation by the Nox1-Centered NADPH Oxidase. | Antioxidants (Basel) | 2024 | 39334772 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1666/papers?page=4